(August 19th, 2015) i-SENS is categorized as one of the best biotech companies in Korea. Within this category, the company has delivered a double-digit increase in operating profits – up by 14.8% from the same quarter last year. According to the article, the company says rewards from long-term investment in R&D are expected in near future.
Copyright ©2010 – 2014 i-SENS. Inc. All rights reserved.
This website is intended for the worldwide audience and may contain products or information not accessible or valid in your country. Please be aware that we are not responsible for any such information that may not comply with your country’s regulations or usage.